Acorda Therapeutics Inc (ACORQ)
OTCMKTS: ACORQ · Delayed Price · USD
0.339
0.00 (0.00%)
Apr 17, 2024, 12:00 AM EDT - Market open

Acorda Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2002
Revenue
117.63118.57129.07152.97192.41471.43588.29519.6492.66401.48
Upgrade
Revenue Growth (YoY)
-0.79%-8.14%-15.62%-20.50%-59.19%-19.86%13.22%5.47%22.71%19.34%
Upgrade
Cost of Revenue
15.2830.3340.7933.5134.8597.64111.96108.1192.9380.62
Upgrade
Gross Profit
102.3588.2388.28119.45157.56373.79476.33411.49399.73320.87
Upgrade
Selling, General & Admin
89.7106.26124.4152.58192.85172.25181.62235.44205.63201.81
Upgrade
Research & Development
5.155.810.4223.0160.08106.38166.11203.44149.2173.47
Upgrade
Other Operating Expenses
282.0918.2130.7692.79303.21.67320.52-9.9-0.416.99
Upgrade
Operating Expenses
376.94130.27165.58268.38556.13280.31668.25428.97354.43282.27
Upgrade
Operating Income
-274.59-42.04-77.3-148.92-398.5793.49-191.91-17.4845.338.59
Upgrade
Interest Expense / Income
31.5330.230.0430.5721.8721.618.6616.5315.479.29
Upgrade
Other Expense / Income
-10.1-36.991.74-71.83-146.1951.4741.317.2810.461.29
Upgrade
Pretax Income
-296.02-35.25-109.07-107.67-274.2520.42-251.89-41.2819.3728.01
Upgrade
Income Tax
-43.1730.67-5.12-8.07-1.28-13.26-28.53-6.678.3110.34
Upgrade
Net Income
-252.85-65.92-103.95-99.59-272.9733.68-223.36-34.6211.0617.67
Upgrade
Net Income Growth
---------37.43%7.49%
Upgrade
Shares Outstanding (Basic)
1110000000
Upgrade
Shares Outstanding (Diluted)
1110000000
Upgrade
Shares Change
22.85%90.38%31.38%1.98%0.47%2.92%1.64%3.76%2.53%2.07%
Upgrade
EPS (Basic)
-203.57-65.23-195.80-246.40-688.6086.40-583.20-91.2031.2051.60
Upgrade
EPS (Diluted)
-203.57-65.23-195.80-246.40-688.6085.20-583.20-91.2030.0050.40
Upgrade
EPS Growth
---------40.48%7.69%
Upgrade
Free Cash Flow
-14.25-21.06-41.51-65.4-218.59117.4783.4523.4632.5669.57
Upgrade
Free Cash Flow Per Share
-11.47-20.83-78.17-161.79-551.51299.85217.6962.1992.52202.86
Upgrade
Gross Margin
87.01%74.42%68.40%78.09%81.89%79.29%80.97%79.19%81.14%79.92%
Upgrade
Operating Margin
-233.43%-35.45%-59.89%-97.36%-207.15%19.83%-32.62%-3.36%9.20%9.61%
Upgrade
Profit Margin
-214.95%-55.59%-80.54%-65.11%-141.87%7.14%-37.97%-6.66%2.24%4.40%
Upgrade
Free Cash Flow Margin
-12.11%-17.76%-32.16%-42.75%-113.61%24.92%14.18%4.51%6.61%17.33%
Upgrade
Effective Tax Rate
------64.92%--42.91%36.91%
Upgrade
EBITDA
-232.8927.76-45.09-35.8-217.853.5-209.99-3.1749.8545.77
Upgrade
EBITDA Margin
-197.98%23.41%-34.93%-23.40%-113.20%11.35%-35.69%-0.61%10.12%11.40%
Upgrade
Depreciation & Amortization
31.632.8133.9541.334.5711.4823.2321.5815.018.47
Upgrade
EBIT
-264.49-5.05-79.04-77.09-252.3842.02-233.22-24.7634.8437.3
Upgrade
EBIT Margin
-224.84%-4.26%-61.24%-50.40%-131.17%8.91%-39.64%-4.76%7.07%9.29%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).